These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15337696)

  • 1. Norepinephrine transporter-deficient mice exhibit excessive tachycardia and elevated blood pressure with wakefulness and activity.
    Keller NR; Diedrich A; Appalsamy M; Tuntrakool S; Lonce S; Finney C; Caron MG; Robertson D
    Circulation; 2004 Sep; 110(10):1191-6. PubMed ID: 15337696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autonomic control after blockade of the norepinephrine transporter: a model of orthostatic intolerance.
    Carson RP; Diedrich A; Robertson D
    J Appl Physiol (1985); 2002 Dec; 93(6):2192-8. PubMed ID: 12391111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norepinephrine transporter variant A457P knock-in mice display key features of human postural orthostatic tachycardia syndrome.
    Shirey-Rice JK; Klar R; Fentress HM; Redmon SN; Sabb TR; Krueger JJ; Wallace NM; Appalsamy M; Finney C; Lonce S; Diedrich A; Hahn MK
    Dis Model Mech; 2013 Jul; 6(4):1001-11. PubMed ID: 23580201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered sympathetic nervous reactivity and norepinephrine transporter expression in patients with postural tachycardia syndrome.
    Lambert E; Eikelis N; Esler M; Dawood T; Schlaich M; Bayles R; Socratous F; Agrotis A; Jennings G; Lambert G; Vaddadi G
    Circ Arrhythm Electrophysiol; 2008 Jun; 1(2):103-9. PubMed ID: 19808400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency.
    Shannon JR; Flattem NL; Jordan J; Jacob G; Black BK; Biaggioni I; Blakely RD; Robertson D
    N Engl J Med; 2000 Feb; 342(8):541-9. PubMed ID: 10684912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverse blood pressure rhythm of transgenic hypertensive TGR(mREN2)27 rats: role of norepinephrine and expression of tyrosine-hydroxylase and reuptake1-transporter.
    Lemmer B; Schiffer S; Witte K; Gorbey S
    Chronobiol Int; 2005; 22(3):473-88. PubMed ID: 16076648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norepinephrine transporter-deficient mice respond to anxiety producing and fearful environments with bradycardia and hypotension.
    Keller NR; Diedrich A; Appalsamy M; Miller LC; Caron MG; McDonald MP; Shelton RC; Blakely RD; Robertson D
    Neuroscience; 2006; 139(3):931-46. PubMed ID: 16515844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension.
    Goldstein DS; Holmes C; Sharabi Y; Brentzel S; Eisenhofer G
    Neurology; 2003 Apr; 60(8):1327-32. PubMed ID: 12707437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A polymorphism in the noradrenaline transporter gene is associated with increased blood pressure in patients with resistant hypertension.
    Eikelis N; Marques FZ; Hering D; Marusic P; Head GA; Walton AS; Lambert EA; Esler MD; Sari CI; Schlaich MP; Lambert GW
    J Hypertens; 2018 Jul; 36(7):1571-1577. PubMed ID: 29677047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norepinephrine transport-mediated gene expression in noradrenergic neurogenesis.
    Hu YF; Caron MG; Sieber-Blum M
    BMC Genomics; 2009 Apr; 10():151. PubMed ID: 19356247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial orthostatic tachycardia due to norepinephrine transporter deficiency.
    Robertson D; Flattem N; Tellioglu T; Carson R; Garland E; Shannon JR; Jordan J; Jacob G; Blakely RD; Biaggioni I
    Ann N Y Acad Sci; 2001 Jun; 940():527-43. PubMed ID: 11458707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular norepinephrine clearance by the norepinephrine transporter is required for skeletal homeostasis.
    Ma Y; Krueger JJ; Redmon SN; Uppuganti S; Nyman JS; Hahn MK; Elefteriou F
    J Biol Chem; 2013 Oct; 288(42):30105-30113. PubMed ID: 24005671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating dihydroxyphenylglycol and norepinephrine concentrations during sympathetic nervous system activation in patients with pheochromocytoma.
    Atuk NO; Hanks JB; Weltman J; Bogdonoff DL; Boyd DG; Vance ML
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1609-14. PubMed ID: 7989464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the sympathetic nervous system in Schlager genetically hypertensive mice.
    Davern PJ; Nguyen-Huu TP; La Greca L; Abdelkader A; Head GA
    Hypertension; 2009 Oct; 54(4):852-9. PubMed ID: 19667247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological and catecholamine response to sympathetic stimulation in turner syndrome.
    Zuckerman-Levin N; Zinder O; Greenberg A; Levin M; Jacob G; Hochberg Z
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):410-5. PubMed ID: 16584513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of plasma levels of catechols in neurogenic orthostatic hypotension.
    Goldstein DS; Polinsky RJ; Garty M; Robertson D; Brown RT; Biaggioni I; Stull R; Kopin IJ
    Ann Neurol; 1989 Oct; 26(4):558-63. PubMed ID: 2510587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic and tracer methods to study sympathetic function in primary hypertension.
    Goldstein DS; Eisenhofer G; Garty M; Sax FL; Keiser HR; Kopin IJ
    Clin Exp Hypertens A; 1989; 11 Suppl 1():173-89. PubMed ID: 2743589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norepinephrine transporter inhibition alters the hemodynamic response to hypergravitation.
    Strempel S; Schroeder C; Hemmersbach R; Boese A; Tank J; Diedrich A; Heer M; Luft FC; Jordan J
    J Appl Physiol (1985); 2008 Mar; 104(3):756-60. PubMed ID: 18187607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Episodic catatonia, hypertension, and tachycardia: elevated plasma catecholamines.
    Wheeler AH; Ziegler MG; Insel PA; Motulsky HJ
    Neurology; 1985 Jul; 35(7):1053-5. PubMed ID: 4010946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic activity and cardiovascular risk factors in young men in the low, normal, and high blood pressure ranges.
    Flaa A; Mundal HH; Eide I; Kjeldsen S; Rostrup M
    Hypertension; 2006 Mar; 47(3):396-402. PubMed ID: 16446389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.